▶ 調査レポート

大麻薬の世界市場(~2026年)

• 英文タイトル:Global Cannabis Drug Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。大麻薬の世界市場(~2026年) / Global Cannabis Drug Market Size, Status and Forecast 2020-2026 / MRC2-11QY11242資料のイメージです。• レポートコード:MRC2-11QY11242
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は大麻薬のグローバル市場について調査・分析したレポートです。種類別(経口スプレー、カプセル、錠剤)市場規模、用途別(病院、クリニック、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別大麻薬の競争状況、市場シェア
・世界の大麻薬市場:種類別市場規模 2015年-2020年(経口スプレー、カプセル、錠剤)
・世界の大麻薬市場:種類別市場規模予測 2021年-2026年(経口スプレー、カプセル、錠剤)
・世界の大麻薬市場:用途別市場規模 2015年-2020年(病院、クリニック、その他)
・世界の大麻薬市場:用途別市場規模予測 2021年-2026年(病院、クリニック、その他)
・北米の大麻薬市場分析:米国、カナダ
・ヨーロッパの大麻薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの大麻薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の大麻薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの大麻薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Greenwich Biosciences、Abbive、Insys Therapeutics、Bausch Health、GW Pharmaceuticals、Unimed Pharmaceuticals、Indevus Pharmaceuticals、Pharmos
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Drugs with chemicals taken directly from the marijuana plant,or with synthetic versions of chemicals naturally found in marijuana.

Market Analysis and Insights: Global Cannabis Drug Market
The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cannabis Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cannabis Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cannabis Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cannabis Drug market.

Global Cannabis Drug Scope and Market Size
Cannabis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cannabis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Oral Spray
Capsule
Tablets

Market segment by Application, split into
Hospital
Clinic
Other

Based on regional and country-level analysis, the Cannabis Drug market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Cannabis Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Greenwich Biosciences
Abbive
Insys Therapeutics
Bausch Health
GW Pharmaceuticals
Unimed Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis Drug Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Oral Spray
1.2.3 Capsule
1.2.4 Tablets
1.3 Market by Application
1.3.1 Global Cannabis Drug Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cannabis Drug Market Perspective (2015-2026)
2.2 Global Cannabis Drug Growth Trends by Regions
2.2.1 Cannabis Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cannabis Drug Historic Market Share by Regions (2015-2020)
2.2.3 Cannabis Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cannabis Drug Players by Market Size
3.1.1 Global Top Cannabis Drug Players by Revenue (2015-2020)
3.1.2 Global Cannabis Drug Revenue Market Share by Players (2015-2020)
3.2 Global Cannabis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cannabis Drug Revenue
3.4 Global Cannabis Drug Market Concentration Ratio
3.4.1 Global Cannabis Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis Drug Revenue in 2019
3.5 Key Players Cannabis Drug Area Served
3.6 Key Players Cannabis Drug Product Solution and Service
3.7 Date of Enter into Cannabis Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cannabis Drug Breakdown Data by Type (2015-2026)
4.1 Global Cannabis Drug Historic Market Size by Type (2015-2020)
4.2 Global Cannabis Drug Forecasted Market Size by Type (2021-2026)

5 Cannabis Drug Breakdown Data by Application (2015-2026)
5.1 Global Cannabis Drug Historic Market Size by Application (2015-2020)
5.2 Global Cannabis Drug Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Cannabis Drug Market Size (2015-2026)
6.2 North America Cannabis Drug Market Size by Type (2015-2020)
6.3 North America Cannabis Drug Market Size by Application (2015-2020)
6.4 North America Cannabis Drug Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Cannabis Drug Market Size (2015-2026)
7.2 Europe Cannabis Drug Market Size by Type (2015-2020)
7.3 Europe Cannabis Drug Market Size by Application (2015-2020)
7.4 Europe Cannabis Drug Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Cannabis Drug Market Size (2015-2026)
8.2 China Cannabis Drug Market Size by Type (2015-2020)
8.3 China Cannabis Drug Market Size by Application (2015-2020)
8.4 China Cannabis Drug Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Cannabis Drug Market Size (2015-2026)
9.2 Japan Cannabis Drug Market Size by Type (2015-2020)
9.3 Japan Cannabis Drug Market Size by Application (2015-2020)
9.4 Japan Cannabis Drug Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Cannabis Drug Market Size (2015-2026)
10.2 Southeast Asia Cannabis Drug Market Size by Type (2015-2020)
10.3 Southeast Asia Cannabis Drug Market Size by Application (2015-2020)
10.4 Southeast Asia Cannabis Drug Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 Greenwich Biosciences
11.1.1 Greenwich Biosciences Company Details
11.1.2 Greenwich Biosciences Business Overview
11.1.3 Greenwich Biosciences Cannabis Drug Introduction
11.1.4 Greenwich Biosciences Revenue in Cannabis Drug Business (2015-2020))
11.1.5 Greenwich Biosciences Recent Development
11.2 Abbive
11.2.1 Abbive Company Details
11.2.2 Abbive Business Overview
11.2.3 Abbive Cannabis Drug Introduction
11.2.4 Abbive Revenue in Cannabis Drug Business (2015-2020)
11.2.5 Abbive Recent Development
11.3 Insys Therapeutics
11.3.1 Insys Therapeutics Company Details
11.3.2 Insys Therapeutics Business Overview
11.3.3 Insys Therapeutics Cannabis Drug Introduction
11.3.4 Insys Therapeutics Revenue in Cannabis Drug Business (2015-2020)
11.3.5 Insys Therapeutics Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Details
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Cannabis Drug Introduction
11.4.4 Bausch Health Revenue in Cannabis Drug Business (2015-2020)
11.4.5 Bausch Health Recent Development
11.5 GW Pharmaceuticals
11.5.1 GW Pharmaceuticals Company Details
11.5.2 GW Pharmaceuticals Business Overview
11.5.3 GW Pharmaceuticals Cannabis Drug Introduction
11.5.4 GW Pharmaceuticals Revenue in Cannabis Drug Business (2015-2020)
11.5.5 GW Pharmaceuticals Recent Development
11.6 Unimed Pharmaceuticals
11.6.1 Unimed Pharmaceuticals Company Details
11.6.2 Unimed Pharmaceuticals Business Overview
11.6.3 Unimed Pharmaceuticals Cannabis Drug Introduction
11.6.4 Unimed Pharmaceuticals Revenue in Cannabis Drug Business (2015-2020)
11.6.5 Unimed Pharmaceuticals Recent Development
11.7 Indevus Pharmaceuticals
11.7.1 Indevus Pharmaceuticals Company Details
11.7.2 Indevus Pharmaceuticals Business Overview
11.7.3 Indevus Pharmaceuticals Cannabis Drug Introduction
11.7.4 Indevus Pharmaceuticals Revenue in Cannabis Drug Business (2015-2020)
11.7.5 Indevus Pharmaceuticals Recent Development
11.8 Pharmos
11.8.1 Pharmos Company Details
11.8.2 Pharmos Business Overview
11.8.3 Pharmos Cannabis Drug Introduction
11.8.4 Pharmos Revenue in Cannabis Drug Business (2015-2020)
11.8.5 Pharmos Recent Development

12Analyst’s Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cannabis Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Oral Spray
Table 4. Key Players of Capsule
Table 5. Key Players of Tablets
Table 6. Global Cannabis Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Cannabis Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Cannabis Drug Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Cannabis Drug Market Share by Regions (2015-2020)
Table 10. Global Cannabis Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Cannabis Drug Market Share by Regions (2021-2026)
Table 12. Cannabis Drug Market Market Trends
Table 13. Cannabis Drug Market Drivers
Table 14. Cannabis Drug Market Challenges
Table 15. Cannabis Drug Market Restraints
Table 16. Global Cannabis Drug Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Cannabis Drug Market Share by Players (2015-2020)
Table 18. Global Top Cannabis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis Drug as of 2019)
Table 19. Global Cannabis Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cannabis Drug Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cannabis Drug Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Cannabis Drug Market Size Share by Type (2015-2020)
Table 25. Global Cannabis Drug Revenue Market Share by Type (2021-2026)
Table 26. Global Cannabis Drug Market Size Share by Application (2015-2020)
Table 27. Global Cannabis Drug Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Cannabis Drug Market Size Share by Application (2021-2026)
Table 29. North America Cannabis Drug Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Cannabis Drug Market Share by Type (2015-2020)
Table 31. North America Cannabis Drug Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Cannabis Drug Market Share by Application (2015-2020)
Table 33. North America Cannabis Drug Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Cannabis Drug Market Share by Country (2015-2020)
Table 35. Europe Cannabis Drug Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Cannabis Drug Market Share by Type (2015-2020)
Table 37. Europe Cannabis Drug Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Cannabis Drug Market Share by Application (2015-2020)
Table 39. Europe Cannabis Drug Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Cannabis Drug Market Share by Country (2015-2020)
Table 41. China Cannabis Drug Market Size by Type (2015-2020) (US$ Million)
Table 42. China Cannabis Drug Market Share by Type (2015-2020)
Table 43. China Cannabis Drug Market Size by Application (2015-2020) (US$ Million)
Table 44. China Cannabis Drug Market Share by Application (2015-2020)
Table 45. China Cannabis Drug Market Size by Region (US$ Million) (2015-2020)
Table 46. China Cannabis Drug Market Share by Region (2015-2020)
Table 47. Japan Cannabis Drug Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Cannabis Drug Market Share by Type (2015-2020)
Table 49. Japan Cannabis Drug Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Cannabis Drug Market Share by Application (2015-2020)
Table 51. Japan Cannabis Drug Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Cannabis Drug Market Share by Country (2015-2020)
Table 53. Southeast Asia Cannabis Drug Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Cannabis Drug Market Share by Type (2015-2020)
Table 55. Southeast Asia Cannabis Drug Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Cannabis Drug Market Share by Application (2015-2020)
Table 57. Southeast Asia Cannabis Drug Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Cannabis Drug Market Share by Country (2015-2020)
Table 59. Greenwich Biosciences Company Details
Table 60. Greenwich Biosciences Business Overview
Table 61. Greenwich Biosciences Product
Table 62. Greenwich Biosciences Revenue in Cannabis Drug Business (2015-2020) (US$ Million)
Table 63. Greenwich Biosciences Recent Development
Table 64. Abbive Company Details
Table 65. Abbive Business Overview
Table 66. Abbive Product
Table 67. Abbive Revenue in Cannabis Drug Business (2015-2020) (US$ Million)
Table 68. Abbive Recent Development
Table 69. Insys Therapeutics Company Details
Table 70. Insys Therapeutics Business Overview
Table 71. Insys Therapeutics Product
Table 72. Insys Therapeutics Revenue in Cannabis Drug Business (2015-2020) (US$ Million)
Table 73. Insys Therapeutics Recent Development
Table 74. Bausch Health Company Details
Table 75. Bausch Health Business Overview
Table 76. Bausch Health Product
Table 77. Bausch Health Revenue in Cannabis Drug Business (2015-2020) (US$ Million)
Table 78. Bausch Health Recent Development
Table 79. GW Pharmaceuticals Company Details
Table 80. GW Pharmaceuticals Business Overview
Table 81. GW Pharmaceuticals Product
Table 82. GW Pharmaceuticals Revenue in Cannabis Drug Business (2015-2020) (US$ Million)
Table 83. GW Pharmaceuticals Recent Development
Table 84. Unimed Pharmaceuticals Company Details
Table 85. Unimed Pharmaceuticals Business Overview
Table 86. Unimed Pharmaceuticals Product
Table 87. Unimed Pharmaceuticals Revenue in Cannabis Drug Business (2015-2020) (US$ Million)
Table 88. Unimed Pharmaceuticals Recent Development
Table 89. Indevus Pharmaceuticals Company Details
Table 90. Indevus Pharmaceuticals Business Overview
Table 91. Indevus Pharmaceuticals Product
Table 92. Indevus Pharmaceuticals Revenue in Cannabis Drug Business (2015-2020) (US$ Million)
Table 93. Indevus Pharmaceuticals Recent Development
Table 94. Pharmos Business Overview
Table 95. Pharmos Product
Table 96. Pharmos Company Details
Table 97. Pharmos Revenue in Cannabis Drug Business (2015-2020) (US$ Million)
Table 98. Pharmos Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cannabis Drug Market Share by Type: 2020 VS 2026
Figure 2. Oral Spray Features
Figure 3. Capsule Features
Figure 4. Tablets Features
Figure 5. Global Cannabis Drug Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Cannabis Drug Report Years Considered
Figure 10. Global Cannabis Drug Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Cannabis Drug Market Share by Regions: 2020 VS 2026
Figure 12. Global Cannabis Drug Market Share by Regions (2021-2026)
Figure 13. Global Cannabis Drug Market Share by Players in 2019
Figure 14. Global Top Cannabis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Cannabis Drug Revenue in 2019
Figure 16. North America Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Cannabis Drug Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Greenwich Biosciences Revenue Growth Rate in Cannabis Drug Business (2015-2020)
Figure 44. Abbive Revenue Growth Rate in Cannabis Drug Business (2015-2020)
Figure 45. Insys Therapeutics Revenue Growth Rate in Cannabis Drug Business (2015-2020)
Figure 46. Bausch Health Revenue Growth Rate in Cannabis Drug Business (2015-2020)
Figure 47. GW Pharmaceuticals Revenue Growth Rate in Cannabis Drug Business (2015-2020)
Figure 48. Unimed Pharmaceuticals Revenue Growth Rate in Cannabis Drug Business (2015-2020)
Figure 49. Indevus Pharmaceuticals Revenue Growth Rate in Cannabis Drug Business (2015-2020)
Figure 50. Pharmos Revenue Growth Rate in Cannabis Drug Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed